Biolargo Inc (BLGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,763 | 155 | 92 | 151 | 129 |
| Receivables | 41 | 6 | 4 | 12 | 11 |
| Inventories | 37 | 26 | 30 | 54 | 62 |
| TOTAL | $1,891 | $231 | $126 | $217 | $202 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 3 |
| Other Non-Current Assets | 19 | 30 | 41 | 52 | 42 |
| TOTAL | $19 | $30 | $41 | $52 | $44 |
| Total Assets | $1,910 | $261 | $167 | $269 | $246 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 325 | 495 | 407 | 339 | 707 |
| Other current liabilities | 135 | 100 | N/A | 100 | 100 |
| TOTAL | $460 | $653 | $732 | $558 | $1,374 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 19 | 53 |
| Other Non-Current Liabilities | 330 | 48 | 373 | 0 | 390 |
| TOTAL | $309 | $N/A | $N/A | $N/A | $390 |
| Total Liabilities | $769 | $653 | $732 | $558 | $1,764 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,272 | 83,000 | 79,838 | 72,081 | 60,700 |
| Common Shares | 57 | 55 | 50 | 47 | 40 |
| Retained earnings | -84,076 | -79,020 | -75,328 | -72,799 | -67,465 |
| Other shareholders' equity | 749 | 61 | -137 | 0 | 0 |
| TOTAL | $1,141 | $-392 | $-565 | $-290 | $-1,518 |
| Total Liabilities And Equity | $1,910 | $261 | $167 | $269 | $246 |